Novoray Corp
SSE:688300
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
P/S
Price to Sales (P/S) ratio shows how much investors pay for each dollar of a company`s sales. It`s calculated by dividing the company`s market value by its total revenue.
Price to Sales (P/S) ratio shows how much investors pay for each dollar of a company`s sales. It`s calculated by dividing the company`s market value by its total revenue.
Valuation Scenarios
If P/S returns to its 3-Year Average (15), the stock would be worth ¥67.87 (20% downside from current price).
| Scenario | P/S Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 18.9 | ¥85.18 |
0%
|
| 3-Year Average | 15 | ¥67.87 |
-20%
|
| 5-Year Average | 14.1 | ¥63.65 |
-25%
|
| Industry Average | 2.6 | ¥11.85 |
-86%
|
| Country Average | 2.8 | ¥12.48 |
-85%
|
Forward P/S
Today’s price vs future revenue
| Today's Market Cap | Revenue | Forward P/S | ||
|---|---|---|---|---|
|
¥22.2B
|
/ |
Oct 2025
¥1.1B
|
= |
|
|
¥22.2B
|
/ |
Dec 2025
¥1.2B
|
= |
|
|
¥22.2B
|
/ |
Dec 2026
¥1.5B
|
= |
|
|
¥22.2B
|
/ |
Dec 2027
¥1.8B
|
= |
|
Forward P/S shows whether today’s P/S still looks high or low once future revenue are taken into account.
Peer Comparison
| Market Cap | P/S | P/E | ||||
|---|---|---|---|---|---|---|
| CN |
N
|
Novoray Corp
SSE:688300
|
20.6B CNY | 18.9 | 71.8 | |
| SA |
|
Saudi Basic Industries Corporation SJSC
SAU:2010
|
228.3B SAR | 2 | -8.8 | |
| ID |
|
Chandra Asri Pacific PT Tbk
OTC:PTPIF
|
45.6B USD | 6.5 | 41.8 | |
| US |
|
Dow Inc
NYSE:DOW
|
28.4B USD | 0.7 | -11.1 | |
| ID |
|
Chandra Asri Petrochemical Tbk PT
IDX:TPIA
|
458.5T IDR | 3.9 | 24.8 | |
| UK |
|
LyondellBasell Industries NV
NYSE:LYB
|
23.6B USD | 0.8 | -32 | |
| TW |
|
Nan Ya Plastics Corp
TWSE:1303
|
726.5B TWD | 2.8 | 160.8 | |
| CN |
|
Hengli Petrochemical Co Ltd
SSE:600346
|
156.4B CNY | 0.8 | 17.5 | |
| KR |
|
LG Chem Ltd
KRX:051910
|
31.9T KRW | 0.7 | -17.5 | |
| CN |
|
Rongsheng Petrochemical Co Ltd
SZSE:002493
|
136.3B CNY | 0.4 | 185.1 | |
| CN |
G
|
Guangzhou Tinci Materials Technology Co Ltd
SZSE:002709
|
120.7B CNY | 6.1 | 42.1 |
Market Distribution
| Min | 0 |
| 30th Percentile | 1.5 |
| Median | 2.8 |
| 70th Percentile | 5.4 |
| Max | 5 034 353.9 |
Other Multiples
Novoray Corp
Glance View
In the bustling landscape of modern technology companies, Novoray Corp has carved out a niche with its cutting-edge solutions in the realm of imaging and radiography technology. Founded by a group of visionary engineers and entrepreneurs, Novoray emerged from the need to innovate within medical and industrial sectors. The company has honed its expertise in developing advanced imaging systems that harness the power of digital radiography and computed tomography. These systems find applications in diverse fields ranging from healthcare diagnostics to industrial non-destructive testing, offering unparalleled clarity and precision. Novoray's commitment to research and development is evident in its consistently innovative product lineup, attracting a loyal clientele composed of hospitals, manufacturing units, and research institutions worldwide. At the heart of Novoray's business model lies its multi-faceted revenue streams. The company generates income by selling state-of-the-art imaging equipment, complemented by service contracts for maintenance and upgrades, ensuring clients have continuous access to the latest technology. Beyond hardware sales, Novoray has strategically boosted its recurring revenue through software solutions that enhance image processing and diagnostics. This software-as-a-service (SaaS) approach facilitates smooth integration into clients' existing systems, driving efficiency and improving outcomes. Additionally, Novoray capitalizes on training and consultancy services, empowering clients to leverage their technology to its full potential. Through these various avenues, Novoray Corp not only sustains its financial health but also secures a reputation as a leader in precision imaging solutions.